Stacy Lindley is Vice President and Head of Emerging Biopharma Alliance Management at IQVIA. In this role, Stacy leads strategic oversight and solution development for emerging and mid-size biopharma clients. She and her team work closely with Clinical Operations and the broader IQVIA organization to deliver more precise and predictable clinical programs designed to maximize commercial value. Supported by cross-functional colleagues within Business Development, Clinical Operations and the broader IQVIA organization, she is responsible for working directly with emerging biopharma clients to deliver more precise and predictable programs designed to maximize commercial value. Stacy began her career in the biopharmaceutical industry 21 years ago at GlaxoSmithKline and she holds a Pharm D from Mercer University.
113ABC, Level 100